» Articles » PMID: 21251352

Awareness of Olfactory Deficits in Healthy Aging, Amnestic Mild Cognitive Impairment and Alzheimer's Disease

Overview
Publisher Elsevier
Specialties Geriatrics
Psychiatry
Date 2011 Jan 22
PMID 21251352
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Olfactory dysfunction is present in early Alzheimer's disease (AD), and has now been reported in people with amnestic mild cognitive impairment (aMCI). Recent evidence suggests that unawareness of an olfactory deficit may predict which MCI patients will subsequently meet AD criteria. However, important methodological limitations challenge this suggestion. While addressing some of the limitations of previous research, this preliminary study explores unawareness of olfactory deficits as a predictive factor of future AD among people with aMCI.

Methods: Twenty-five participants with aMCI, 25 AD patients, and 22 healthy elderly participants underwent testing of olfactory identification. Subjective reports regarding perceived decline in olfactory detection and olfactory identification were also obtained. A subset of participants was reassessed 12 months later.

Results: Control participants performed better than both aMCI and AD patients on olfactory identification. Almost uniformly, participants did not report decline in either olfactory detection or identification. Prediction of olfactory identification scores from subjective reports of olfactory function was poor, and awareness of olfactory decline bore no relationship to the likelihood of aMCI patients progressing to AD by the 12-month review.

Conclusions: Treating awareness of olfactory function as a unitary construct can be misleading, and there is a poor relationship between subjective and objective measures of olfactory ability. Our preliminary data suggest that unawareness of olfactory decline does not improve the identification of patients with MCI who are more likely to be in the prodromal phase of AD. Replication in a larger cohort is needed to support these findings.

Citing Articles

Olfactory Identification as a Biomarker for Cognitive Impairment: Insights from Healthy Aging, Subjective Cognitive Decline, and Mild Cognitive Impairment.

Bouhaben J, Delgado-Lima A, Delgado-Losada M Eur J Investig Health Psychol Educ. 2024; 14(12):2978-3000.

PMID: 39727504 PMC: 11675861. DOI: 10.3390/ejihpe14120196.


Olfactory and cognitive decrements in 1991 Gulf War veterans with gulf war illness/chronic multisymptom illness.

Chao L Environ Health. 2024; 23(1):14.

PMID: 38291474 PMC: 10825982. DOI: 10.1186/s12940-024-01058-2.


Disparity of smell tests in Alzheimer's disease and other neurodegenerative disorders: a systematic review and meta-analysis.

Liu S, Jiang Z, Zhao J, Li Z, Li R, Qiu Y Front Aging Neurosci. 2023; 15:1249512.

PMID: 37744388 PMC: 10512741. DOI: 10.3389/fnagi.2023.1249512.


Seed-induced Aβ deposition alters neuronal function and impairs olfaction in a mouse model of Alzheimer's disease.

Ziegler-Waldkirch S, Friesen M, Loreth D, Sauer J, Kemna S, Hilse A Mol Psychiatry. 2022; 27(10):4274-4284.

PMID: 35869271 PMC: 9718674. DOI: 10.1038/s41380-022-01686-5.


Olfactory Decline in Older Adults with Mild Cognitive Impairment with and without Comorbidities.

Touliou K, Maglaveras N, Bekiaris E Diagnostics (Basel). 2021; 11(12).

PMID: 34943465 PMC: 8700609. DOI: 10.3390/diagnostics11122228.